Gilead Sciences (NASDAQ:GILD) and Amgen (NASDAQ:AMGN) with outperform ratings. The investment firm said its bullish ratings on Gilead and Amgen were based on upside expectations for key assets to ...

At the close in NYSE, the Dow Jones Industrial Average gained 0.79% to hit a new all time high, while the S&P 500 index gained 0.47%, and the NASDAQ Composite index added 0.28%.

In order to multiply the amount of plants in your garden, understanding what rooting hormones are and the types available are ...

Alongside immunotherapy or chemo, the wearable device helped patients live longer in a trial, though the results are somewhat controversial.

Oncolytics Biotech is seeking accelerated approval for its lead cancer therapy, pelareorep, with plans to start a ...

Merck (MRK) says it Capvaxive vaccine showed positive immune responses in a Phase 3 trial for adults at risk for pneumonia.

Former Merck CEO Ken Frazier and former American Express CEO Ken Chenault have warned companies pulling back from diversity, ...

Nodenza Venture Partners launched Focus on international early-stage and pre-commercial biotech & medtech opportunities New York, October 16, 2024 – Nodenza Venture Partners (“Nodenza”) has been ...

Globally recognised as a first-line standard of care, the public funding of ERBITUX® (cetuximab) [1] marks an important development for people living with left-sided RAS wild-type and BRAF wild-type ...

It’s similar to some major blue-chip stocks. These include the Coca-Cola Co. (KO) at $303 billion and Merck & Co. (MRK) at ...

Pfizer is already active in the protein degrader area, having partnered with Arvinas in a $2 billion-plus deal signed in 2021 ...

Announces the Appointment of Dr Liz Holmes as Chief Medical Officer Newly established role at further strengthens leadership team and supports global growth Dr Liz Holmes’ rare disease and oncology ...